Agreed, previously I thought the investor conference today would be due to great results from the FDA and to get through the new set of trials, however, I now think it is because they need to go the standard path before submission for human clinical trials, which will take “several quarters”, and so need additional funding for the time un accounted for.
I also don’t see there being many significant announcements between now and when the “several quarters” are finished to keep the SP going upward.
I still think this could be a great long term hold, but agree that it could be worth sitting on the fence a bit for now.
Ann: Update on meeting with US FDA, page-8
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.015(3.30%) |
Mkt cap ! $104.2M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.0¢ | 45.5¢ | $64.42K | 139.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71081 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 28300 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |